Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Goubau

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Vaccine|January 1, 1992
Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccineP Goubau, V Van Gerven, A Safary, et al.
The Journal of General Virology|February 1, 1996
The three human T-lymphotropic virus type I subtypes arose from three geographically distinct simian reservoirsH F Liu, P Goubau, M Van Brussel, et al.
HIV Medicine|February 19, 2010
HIV-1 proviral resistance mutations: usefulness in clinical practiceB Kabamba-Mukadi, A Duquenne, P Henrivaux, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 28, 2007
Dual infection with polyomavirus BK and acyclovir-resistant herpes simplex virus successfully treated with cidofovir in a bone marrow transplant recipientG Andrei, P Fiten, P Goubau, et al.
Vaccine|September 1, 1987
Multicentre dose range study of a yeast-derived hepatitis B vaccineG Wiedermann, N Scheiermann, P Goubau, et al.
AIDS Research and Human Retroviruses|February 1, 1995
HTLV-negative and HTLV type I-positive tropical spastic paraparesis in northeastern BrazilC M Costa, P Goubau, H F Liu, et al.
Acta Clinica Belgica|January 1, 1989
A clinical and sero-epidemiological study of 190 Belgian patients suffering from Lyme borreliosisG Bigaignon, J P Tomasi, P Goubau, et al.
Journal of Molecular Evolution|June 6, 1998
Evolutionary rate and genetic heterogeneity of human T-cell lymphotropic virus type II (HTLV-II) using isolates from European injecting drug usersM Salemi, A M Vandamme, C Gradozzi, et al.
Journal of Virological Methods|March 1, 1995
Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCRA M Vandamme, S Van Dooren, W Kok, et al.
Journal of Virology|April 29, 1998
African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe PygmiesA M Vandamme, M Salemi, M Van Brussel, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Vaccine|January 1, 1992
Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccineP Goubau, V Van Gerven, A Safary, et al.
The Journal of General Virology|February 1, 1996
The three human T-lymphotropic virus type I subtypes arose from three geographically distinct simian reservoirsH F Liu, P Goubau, M Van Brussel, et al.
HIV Medicine|February 19, 2010
HIV-1 proviral resistance mutations: usefulness in clinical practiceB Kabamba-Mukadi, A Duquenne, P Henrivaux, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 28, 2007
Dual infection with polyomavirus BK and acyclovir-resistant herpes simplex virus successfully treated with cidofovir in a bone marrow transplant recipientG Andrei, P Fiten, P Goubau, et al.
Vaccine|September 1, 1987
Multicentre dose range study of a yeast-derived hepatitis B vaccineG Wiedermann, N Scheiermann, P Goubau, et al.
AIDS Research and Human Retroviruses|February 1, 1995
HTLV-negative and HTLV type I-positive tropical spastic paraparesis in northeastern BrazilC M Costa, P Goubau, H F Liu, et al.
Acta Clinica Belgica|January 1, 1989
A clinical and sero-epidemiological study of 190 Belgian patients suffering from Lyme borreliosisG Bigaignon, J P Tomasi, P Goubau, et al.
Journal of Molecular Evolution|June 6, 1998
Evolutionary rate and genetic heterogeneity of human T-cell lymphotropic virus type II (HTLV-II) using isolates from European injecting drug usersM Salemi, A M Vandamme, C Gradozzi, et al.
Journal of Virological Methods|March 1, 1995
Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCRA M Vandamme, S Van Dooren, W Kok, et al.
Journal of Virology|April 29, 1998
African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe PygmiesA M Vandamme, M Salemi, M Van Brussel, et al.
Pageof 11